Flavonoids as Potential Modulators of Pancreatic Lipase Catalytic Activity
Pharmaceutics · 25.01.2025 · 17 (2) · 163
DOI: 10.3390/pharmaceutics17020163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 25.01.2025. Verfasst von Sílvia Rocha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório Associado para a Química Verde (LAQV), Rede de Química e Tecnologia (REQUIMTE), Laboratory of Applied Chemistry, Department of Chemical S…. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES), Fundação para a Ciência e Tecnologia, Scientific Employment Stimulus-Individual Call.
Abstract (Originalsprache)
Background/Objectives: Obesity has reached pandemic proportions, with predictions suggesting that, by 2030, over 1.5 billion people will be affected. Pancreatic lipase (PL), the enzyme primarily responsible for the absorption of dietary lipids, presents a potential target for obesity management. However, while porcine pancreatic lipase (PPL) is commonly used as the enzyme source for screening potential inhibitors, its effect on human pancreatic lipase (HPL) is rarely reported. This work aimed to screen the inhibitory effects of a library of flavonoids with different functional groups on the activity of PL from the human pancreas (triacylglycerol acyl hydrolase, EC 3.1.1.3) and compare it to the effects of the porcine pancreas (type II, EC 3.1.1.3), establishing, whenever possible, a structure–activity relationship. Methods: The inhibitory effects of a library of 48 flavonoids with different hydroxy, glycosyl, rutinosyl, galloyl, and extended alkyl groups were evaluated against PPL and HPL. The kinetic parameters and inhibitory mechanisms of the most active flavonoids were determined, and in silico docking studies of the more potent flavonoids were also performed, using the active site of HPL. Results/Conclusions: Variations in enzyme catalytic activity were observed depending on the source of the enzyme. The inhibitory effect was particularly influenced by the presence of extended alkyl groups at the C-3 of the C-ring and the C2=C3 double bond of the C-ring and the presence of a pyrogallol group at the C-2′, C-3′ and C-4′ of the B-ring. Docking results showed a strong correlation between docking scores and observed inhibitory activities, highlighting the critical role of specific substituents on the flavonoid backbone in enhancing detailed interaction dynamics with key amino acids. Compounds 28, 29, and 30, with alkyl groups, showed the highest docking scores, interacting with residues HIS151, PHE215, ARG256, and HIS263. Further analysis also revealed that specific substituents improved pocket occupancy and formed additional interactions with residues TYR114, PRO180, ILE209, and PHE215, which are crucial for inhibition. These binding characteristics closely mimic those observed with orlistat, reinforcing their mechanistic similarities in inhibiting HPL and validating their inhibitory activities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório Associado para a Química Verde (LAQV), Rede de Química e Tecnologia (REQUIMTE), Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterb…
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
- Laboratório Associado para a Química Verde (LAQV), Rede de Química e Tecnologia (REQUIMTE), Department of Chemistry, University of Aveiro, 3800-193 Aveiro, Portugal.
- UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
- Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
ORCID-Profile: Sílvia Rocha, Marisa Freitas, Ismael Rufino, Natália Aniceto, Artur M S Silva, Félix Carvalho, Rita C Guedes, Eduarda Fernandes
Förderung
- Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES)
- Fundação para a Ciência e Tecnologia
- Scientific Employment Stimulus-Individual Call
- PT national funds
Zitieren
APA
Rocha, S., Proença, C., Araújo, A. N., Freitas, M., Rufino, I., Aniceto, N., Silva, A. M. S., Carvalho, F., Guedes, R. C., & Fernandes, E. (2025). Flavonoids as Potential Modulators of Pancreatic Lipase Catalytic Activity. Pharmaceutics, 17(2), 163. https://doi.org/10.3390/pharmaceutics17020163
Vancouver
Rocha S, Proença C, Araújo AN, Freitas M, Rufino I, Aniceto N, et al. Flavonoids as Potential Modulators of Pancreatic Lipase Catalytic Activity. Pharmaceutics. 2025;17(2):163. doi:10.3390/pharmaceutics17020163
BibTeX
@article{Rocha2025,
author = {Rocha, Sílvia and Proença, Carina and Araújo, Alberto N and Freitas, Marisa and Rufino, Ismael and Aniceto, Natália and Silva, Artur M S and Carvalho, Félix and Guedes, Rita C and Fernandes, Eduarda},
title = {Flavonoids as Potential Modulators of Pancreatic Lipase Catalytic Activity},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {2},
pages = {163},
doi = {10.3390/pharmaceutics17020163}
}
EUVIMED